From Nasdaq:

Science Applications International Corporation (SAIC) is set to report earnings for the quarter ending January 31, 2024. Analysts predict an earnings per share of $1.41, a 30.88% decrease from the previous year. SAIC has outperformed expectations in the past year, with a 2024 Price to Earnings ratio of 18.17, indicating potential growth.

Acurx Pharmaceuticals, Inc. (ACXP) will report earnings for the quarter ending December 31, 2023. Analysts forecast an earnings per share of $-0.26, a 7.14% increase from the same quarter last year. ACXP missed expectations in the 4th quarter of 2022, with a 2023 Price to Earnings ratio of -2.63 compared to industry peers.

Exagen Inc. (XGN) is expected to report earnings for the quarter ending December 31, 2023. Analysts expect an earnings per share of $-0.41, a 29.31% increase from the previous year. XGN has consistently beaten expectations in the past year, with a 2023 Price to Earnings ratio of -1.19 compared to the industry ratio of 1.80.



Read more at Nasdaq:: Pre-Market Earnings Report for March 18, 2024 : SAIC, ACXP, XGN